In this Q&A, Randa Wahid of Indero, and Lyn Mursalo, a freelance clinical research professional, share how sponsors and CROs ...

The upcoming meeting of the European Association for the Study of Diabetes will feature results from clinical trials in types 1 and 2 diabetes and obesity and new clinical practice guidelines.

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes ...

Pfizer Inc. (NYSE:PFE) is one of the best growth stocks under $50 to buy now. On September 8, Pfizer Inc. (NYSE:PFE) and ...

As part of the collaboration, PhaseV's Trial Optimizer platform will be integrated into Bioforum's current biometric services.

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today shar ...

A minimally invasive procedure with medical management was nonsuperior to medical management alone at 180 days in a cohort of ...

BioAtla's ozuriftamab vedotin advances to phase 3 trials for HPV-positive oropharyngeal cancer, aiming for accelerated FDA ...

We read with great interest the Article by Shawn D St Peter and colleagues1 showing that an antibiotics-first approach in children with uncomplicated appendicitis is inferior to appendicectomy in ...

Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathwayEvaluating complementary funding ...

Although the stock could soar on clinical progress, it looks too risky for most investors. We should know a lot more by year-end. The weight-management market is arguably the hottest therapeutic area ...